Skip to content

Pilot Study on the Application of Optoacoustic Imaging in Dermatology

Pilot Study on the Application of Optoacoustic Imaging in Dermatology

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037749
Enrollment
25
Registered
2025-08-26
Start date
2023-12-15
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exploratory study in multiple dermatological diseases with a focus on optoacoustic imaging

Interventions

Group 1: Patients with various dermatological diseases (e.g. psoriasis, eczema, lupus erythematosus, scleroderma, dermatomyositis, lichen planus, prurigo, autoimmune blistering dermatoses, chronic wou

Sponsors

Klinik und Poliklinik für Dermatologie und Allergologie am Biederstein
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with inflammatory, autoimmune, neoplastic or metabolic skin diseases (e.g. psoriasis, eczema, lupus, scleroderma, dermatomyositis, lichen planus, prurigo, autoimmune blistering dermatoses, wounds, diabetes, naevi, melanoma, nail disorders). Optoacoustic control measurements on healthy skin areas of the same patients.

Exclusion criteria

Exclusion criteria: - Pregnancy and lactation - Psychiatric comorbidities

Design outcomes

Primary

MeasureTime frame
Exploratory Optoacoustic parameters - Visualization of fine skin microvasculature - Vascular features - Distribution of melanin - Functionality of capillaries - Water and lipid content Comparison - Clinical skin findings - Disease severity scores (e.g., PASI, EASI, depending on disease) - Optoacoustic control measurements on healthy skin Correlation - Corneometry (skin hydration) - TEWL (transepidermal water loss) - OCT (epidermal thickness, vascular supply, skin roughness)

Secondary

MeasureTime frame
- Image quality / technical feasibility (artifacts, reproducibility, limitations vs. OCT) - Functional tests (blood pressure cuff, heated coupling medium) - Combination with OCT, corneometry, TEWL - Development/validation of quantitative biomarkers (e.g., vessel density, blood volume)

Countries

Germany

Contacts

Public ContactUlf Darsow

TUM Universtitätsklinikum

ulf.darsow@tum.de089 4140 8499

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jul 12, 2026